Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
The institution will be spread over an area of more than 8 acres
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
These approvals mark significant progress for Venus Remedies in expanding its market presence
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Subscribe To Our Newsletter & Stay Updated
